(Q80167322)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Pascal Richette

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Thomas Bardin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Rheumatology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

338-42; quiz 343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

cites work

Clinical practice. Gout

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

1 reference

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

1 reference

7 January 2021

Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

7 January 2021

Gout: on the brink of novel therapeutic options for an ancient disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

7 January 2021

Diseases associated with calcium pyrophosphate deposition disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

7 January 2021

Recent advances in the management of gout and hyperuricemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

7 January 2021

Current management of gout in patients unresponsive or allergic to allopurinol

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

7 January 2021

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

7 January 2021

Urate oxidase (rasburicase) for treatment of severe tophaceous gout

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0214

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932713%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference